Drug Transporter (DT) Information

General Information of DT
DT ID DTD0026
Gene Name SLC22A11
Protein Name Organic anion transporter 4
Gene ID
55867
UniProt ID
Q9NSA0
TCDB ID
2.A.1.19.10
3D Structure

Modelled DT Structure

Method: multi-sequence alignment based machine learning

Detail: Structure Info

Synonyms OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4
DT Family Major Facilitator Superfamily (MFS)
Organic Cation Transporter (OCT) Family
Tissue Specificity Detected in placenta and kidney.
Function This transporter mediates saturable uptake of estrone sulfate, dehydroepiandrosterone sulfate and related compounds.
Disease(s) Human immunodeficiency virus infection [ICD-11: 1C62.Z]
Hypercholesterolemia [ICD-11: 5C80.0]
Indigestion [ICD-11: DD90]
Leukemia [ICD-11: 2A60-2B33]
Medical abortion [ICD-11: JA00.1]
Gram-positive & negative bacteria infections [ICD-11: 1A00-1H0Z]
Endogenous Substrate(s) Dehydroepiandrosterone sulfate; Diuretics; Na+; Bile salts; Dehydroepiandrosterone sulfate
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            9 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Bumetanide
 Approved Drug Info Edema associated with congestive heart failure BD10 [1]
Dinoprostone
 Approved Drug Info Medical abortion JA00.1 [2]
Estrone sulfate
 Approved Drug Info Menopausal symptoms MF32 [3]
L-glutamic acid
 Approved Drug Info Schizophrenia 6A20 [4]
Levocetirizine
 Approved Drug Info Allergy 4A8Z [5]
Methotrexate
 Approved Drug Info Leukemia 2A60-2B33 [6]
Pravastatin
 Approved Drug Info Hypercholesterolemia 5C80.0 [7]
Tetracycline
 Approved Drug Info Gram-positive & negative bacteria infections 1A00-1H0Z [8]
Zidovudine
 Approved Drug Info Human immunodeficiency virus infection 1C62.Z [9]

 Clinical Trial Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Uric acid
 Phase 2/3 Drug Info Acute ischemic stroke 8B11 [10]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Prostaglandin f2Alpha
 Preclinical Drug Info Solid tumours 2D4Z [2]

Endogenous Metabolites (EMs) Handled by This DT

 Endogenous Metabolites (EMs)

 Click to Show/Hide the Full List of EMs:            1 EMs in Total
EM Name PubChem CID Detail Experimental Material Ref
Pyridoxic acid
6723
EM Info Identified using HEK293 cells-OAT4 [11]

Drug-DT Affinity Assessed by Cell Line

 Approved Drug

 Click to Show/Hide the Full List of Drug:            8 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Bumetanide Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 306 microM [1]
Dinoprostone Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 0.154 microM [2]
Estrone sulfate Approved Drug Info Oocytes-OAT4 Km = 1.01 microM [12]
Estrone sulfate Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 9.9 microM [6]
Methotrexate Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 17.8 microM [6]
Pravastatin Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 257 microM [7]
Tetracycline Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 122.7 microM [8]
Zidovudine Approved Drug Info Proximal tubule (S2) cells-OAT4 Km = 152 microM [9]

 Clinical Trial Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Uric acid Phase 2/3 Drug Info Human embryonic kidney cells (HEK293)-OAT4 Km = 106 microM [10]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Prostaglandin f2Alpha Preclinical Drug Info Proximal tubule (S2) cells-OAT4 Km = 0.692 microM [2]
Ochratoxin A Investigative Drug Info Proximal tubule (S2) cells-OAT4 Km = 22.9 microM [13]
References
1 Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9.
2 Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.
3 Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. J Pharm Pharmacol. 2006 Nov;58(11):1499-505.
4 The role of the intracellular glutamate gradient in driving organic anion transporter function.
5 Cellular Uptake of Levocetirizine by Organic Anion Transporter 4. J Pharm Sci. 2017 Sep;106(9):2895-2898.
6 Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.
7 Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica. 2007 Apr;37(4):416-26.
8 Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol. 2002 Jan;88(1):69-76.
9 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
10 Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
11 Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys. Drug Metab Dispos. 2018 Feb;46(2):178-188.
12 Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem. 2000 Feb 11;275(6):4507-12.
13 Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim Biophys Acta. 2002 Jun 12;1590(1-3):64-75.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.